Fiche traitement
PCI
Alexandria University • Maladie coronarienne
Suivi actif
À vérifier
Résumé
PCI est développé par Alexandria University. Le traitement est actuellement en À vérifier. Il est associé à Maladie coronarienne. Son objectif thérapeutique principal est À vérifier. Le statut actuel est : suivi actif.
À vérifier
À vérifier
À vérifier
Alexandria University
Egypt
\# WHAT IS THIS STUDY ABOUT?
This study compares two different treatment approaches for patients with two heart conditions occurring simultaneously: a narrowed heart valve (aortic stenosis) and narrowed or blocked heart arteries (coronary artery disease). Both conditions are serious and, when they occur together, place considerable strain on the heart. The heart must work harder to pump blood through the narrowed valve while simultaneously receiving an inadequate blood supply through the blocked coronary arteries.
\# WHY IS THIS STUDY NEEDED?
Until recently, the main treatment option for patients with both conditions was open-heart surgery. This major operation involves opening the chest, temporarily stopping the heart, replacing the heart valve with an artificial valve, and performing coronary artery bypass grafting to restore blood flow around the blocked arteries. Although effective, combined surgery carries significant risks, particularly in older or frailer patients, including prolonged recovery, longer hospital stays (often 2 to 3 weeks), bleeding, kidney injury, and other complications.
A newer, less invasive treatment approach is now available. This involves replacing the heart valve through a thin tube (catheter) inserted through a blood vessel in the groin, without opening the chest, and treating the blocked coronary arteries using a fine wire, a small balloon, and a metal mesh tube (stent) placed inside the artery. This approach, known as transcatheter aortic valve implantation (TAVI) combined with percutaneous coronary intervention (PCI), typically requires a shorter hospital stay of approximately 2 to 4 days and may allow an earlier return to normal activities.
However, sufficient evidence from well-designed studies is not yet available to establish whether this less invasive approach is as safe and effective as conventional surgery in patients who are not considered at high surgical risk.
This study aims to address this evidence gap.
\# WHO CAN JOIN THIS STUDY?
Adults with severe aortic stenosis and significant coronary artery disease who have been assessed by a specialist heart team as having low or intermediate surgical risk may be eligible to participate.
All participants must be considered suitable for both the catheter-based treatment approach and the surgical approach, based on individual coronary anatomy, clinical characteristics, and medical history.
Patients with previous coronary artery bypass graft surgery, severely impaired left ventricular systolic function (ejection fraction below 40%), or a recent myocardial infarction within the previous 6 months are not eligible to participate.
* WHAT WILL HAPPEN IF A PATIENT JOINS THE STUDY?
Participants will receive one of two treatment approaches, selected by a specialist heart team according to individual coronary and valvular anatomy, clinical circumstances, and patient preference:
1. Catheter-based aortic valve replacement combined with coronary artery stenting (TAVI + PCI).
2. Conventional open-heart surgery involving surgical aortic valve replacement and coronary artery bypass grafting (SAVR + CABG).
Regardless of the treatment received, all participants will undergo follow-up assessments at hospital discharge, 30 days, 6 months, and 1 year after the procedure. Follow-up will include clinical assessments and appropriate cardiac investigations.
* WHAT IS THE STUDY MEASURING?
The study will evaluate the incidence of major complications, including all-cause mortality, myocardial infarction, stroke, serious bleeding, and the need for urgent repeat intervention, during the index hospitalization and within 1 year after the procedure.
Additional outcomes will include recovery duration, length of hospital stay, and changes in kidney function.
* WHERE IS THE STUDY TAKING PLACE?
The study is being conducted at Alexandria University Hospitals and other major cardiac centres across Egypt, with a planned total enrolment of 100 participants.
\# WHO IS CONDUCTING THE STUDY?
The study is being conducted by Dr. Moustafa AbdelMohsen Elsayed Madkour, Department of Cardiology and Angiology, Faculty of Medicine, Alexandria University, Egypt, under the supervision of Prof. Dr. Mohamed Ahmed Sobhy and Prof. Dr. Tarek Hussien Elzawawy.
2026-11-05
Début phase actuelle
Non disponible dans les sources synchronisées
Timeline clinique
À vérifier
Début phase actuelle
Non disponible dans les sources synchronisées
Préclinique
Phase 1
Phase 2
Phase 3
Approuvé
Objectif scientifique de l’étude
classification automatique vérifiable
À vérifier
Confiance automatique : 0%
Ce pourcentage n’est pas une probabilité de succès clinique.
Il mesure uniquement la force de la classification automatique de l’objectif scientifique. Le calcul part de 45 points, ajoute 7 points par unité de poids du mot-clé le plus fortement détecté, puis est plafonné à 95 %. Exemple : un score maximal de 2 donne 45 + (2 × 7) = 59 %.
Ce score est heuristique et doit être vérifié dans le protocole ou une publication.
Description affichée depuis l’essai compatible NCT07926022, afin d’éviter le mélange entre plusieurs indications d’une même molécule.
Contrôle de cohérence : 85/100
L’objectif est absent ou classé « Autre » et doit être recalculé à partir du protocole.
Transparence et qualité de la fiche
données vérifiablesClassificationÀ vérifier
Confiance de la fiche85 %
Source principaleSource officielle ou publication indexée
Dernière vérification2026-11-05
Anomalies détectées1
Validation humaineValidation humaine non effectuée
Donnée issue d’une source
Donnée normalisée automatiquement
Interprétation algorithmique
Classification scientifique multi-axes
ne pas confondre statut et résultatÉtat de l’étudeRecrutement en cours
Disponibilité des résultatsRésultats à vérifier
InterprétationImpossible à déterminer
Niveau de preuveNon évaluable
Un essai terminé n’est pas nécessairement positif. Un essai arrêté n’est classé comme échec scientifique que lorsqu’un résultat ou une raison explicite le confirme.
Indicateurs factuels
sans score subjectifPhase enregistréeÀ vérifier
Études associées29
Publications associées19
Statut consolidéSuivi actif
Aucune chance de succès, note d’innovation, potentiel thérapeutique ou probabilité de commercialisation n’est calculé tant qu’un modèle validé et des données suffisantes ne sont pas disponibles.
Historique factuel de la molécule
107 événement(s) daté(s)Cette liste reprend uniquement les dates trouvées dans les registres et publications liés. Elle ne constitue pas une prévision.
| Date | Événement | Source |
|---|---|---|
| 2013-01-01 | Début de l’étudeNCT02038127 | Registre d’essai clinique |
| 2016-09-01 | Début de l’étudeNCT02915107 | Registre d’essai clinique |
| 2021-04-01 | Début de l’étudeNCT04939805 | Registre d’essai clinique |
| 2023-04-08 | Début de l’étudeNCT05410925 | Registre d’essai clinique |
| 2023-06-22 | Début de l’étudeNCT05701358 | Registre d’essai clinique |
| 2023-09-01 | Fin de l’étude prévue / enregistréeNCT02915107 | Registre d’essai clinique |
| 2023-12-20 | Début de l’étudeNCT06154395 | Registre d’essai clinique |
| 2023-12-20 | Début de l’étudeNCT06009874 | Registre d’essai clinique |
| 2024-09-03 | Début de l’étudeNCT06445608 | Registre d’essai clinique |
| 2024-11-03 | Début de l’étudeNCT05903950 | Registre d’essai clinique |
| 2025-04-01 | Début de l’étudeNCT06850831 | Registre d’essai clinique |
| 2025-07-10 | Début de l’étudeNCT06964685 | Registre d’essai clinique |
| 2025-11-01 | Début de l’étudeNCT05785897 | Registre d’essai clinique |
| 2025-11-23 | Début de l’étudeNCT07422688 | Registre d’essai clinique |
| 2025-12-22 | Début de l’étudeNCT07286578 | Registre d’essai clinique |
| 2026-02-01 | Début de l’étudeNCT07926022 | Registre d’essai clinique |
| 2026-04-30 | Fin de l’étude prévue / enregistréeNCT06850831 | Registre d’essai clinique |
| 2026-06-25 | Début de l’étudeNCT07351643 | Registre d’essai clinique |
| 2026-07-01 | Début de l’étudeNCT07684742 | Registre d’essai clinique |
| 2026-07-02 | Début de l’étudeNCT07362446 | Registre d’essai clinique |
| 2026-07-10 | PublicationManagement of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patients. | Coronary artery disease |
| 2026-07-18 | Publication36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. | Critical care (London, England) |
| 2026-08-01 | Début de l’étudeNCT07876336 | Registre d’essai clinique |
| 2026-08-08 | PublicationInterventional Diagnostic Procedure: a Practical Guide for the Assessment of Coronary Vascular Function. | Journal of visualized experiments : JoVE |
| 2026-08-13 | PublicationClinical Impact of Complete Revascularization Before Left Ventricular Assist Device Implantation in Patients With Severe Ischemic Cardiomyopathy. | Artificial organs |
| 2026-08-13 | PublicationInhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammation. | Inflammopharmacology |
| 2026-08-13 | PublicationPrecision Medicine in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia: Toward Personalized Diagnosis and Therapy. | Hemoglobin |
| 2026-08-14 | Début de l’étudeNCT07898696 | Registre d’essai clinique |
| 2026-08-16 | PublicationQuadratus Lumborum Block During Minimally Invasive Colorectal Surgery: A Tool for Enhanced Recovery. | Diseases of the colon and rectum |
| 2026-08-16 | PublicationImpact of dual antiplatelet therapy duration after percutaneous coronary intervention on outcomes in acute coronary syndrome patients with and without chronic kidney disease: a nationwide cohort study. | Renal failure |
| 2026-08-16 | Publication"Two for One", Novel Dual Left Anterior Descending Artery (LAD) Variant: Type XIII. | Cureus |
| 2026-08-16 | PublicationResidual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary intervention. | International journal of cardiology |
| 2026-08-16 | PublicationPreoperative Ultrasound-Guided Stellate Ganglion Block for Prevention of Postoperative Sore Throat After Thoracic Surgery: Study Protocol for a Randomized Controlled Trial. | Journal of pain research |
| 2026-08-16 | PublicationHead-motion-controlled video goggles: preliminary concept for an interactive laparoscopic image display (i-LID). | Journal of laparoendoscopic & advanced surgical techniques. Part A |
| 2026-08-16 | PublicationComparative effectiveness of percutaneous coronary intervention strategies for coronary small-vessel disease: a network meta-analysis of randomized trials. | Annals of medicine |
| 2026-08-16 | PublicationUnbiased metabolomics screening for potential biomarkers in patients with In-stent restenosis post percutaneous coronary intervention. | Scandinavian cardiovascular journal : SCJ |
| 2026-08-16 | PublicationFrailty Status and Outcomes in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a multicentre retrospective cohort study. | European journal of cardiovascular nursing |
| 2026-08-16 | PublicationTherapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice. | American journal of hematology |
| 2026-08-21 | Début de l’étudeNCT07741721 | Registre d’essai clinique |
| 2026-09-01 | PublicationSynergy of Coronary Revascularization and Optimal Drug Therapy in Patients With Ischemic Cardiomyopathy and Reduced Left Ventricular Ejection Fraction. | Kardiologiia |
| 2026-09-28 | Début de l’étudeNCT07875179 | Registre d’essai clinique |
| 2026-09-30 | Début de l’étudeNCT07795398 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT06850831 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT07795398 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT07362446 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT04939805 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT02038127 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT06154395 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT06009874 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT07876336 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT05785897 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT07875088 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT07875179 | Registre d’essai clinique |
| 2026-10-18 | Création de l’enregistrementNCT07879430 | Registre d’essai clinique |
| 2026-10-18 | PublicationCCL17 combined with CCL19 as a nasal adjuvant enhances the immunogenicity of an anti-caries DNA vaccine in rodents. | Acta pharmacologica Sinica |
| 2026-10-19 | Début de l’étudeNCT07879430 | Registre d’essai clinique |
| 2026-10-25 | Création de l’enregistrementNCT05701358 | Registre d’essai clinique |
| 2026-10-25 | Création de l’enregistrementNCT02915107 | Registre d’essai clinique |
| 2026-10-25 | Création de l’enregistrementNCT07892976 | Registre d’essai clinique |
| 2026-10-25 | Création de l’enregistrementNCT07741721 | Registre d’essai clinique |
| 2026-10-25 | Création de l’enregistrementNCT05903950 | Registre d’essai clinique |
| 2026-10-31 | Début de l’étudeNCT07762560 | Registre d’essai clinique |
| 2026-11-01 | Création de l’enregistrementNCT07898696 | Registre d’essai clinique |
| 2026-11-01 | Création de l’enregistrementNCT07898709 | Registre d’essai clinique |
| 2026-11-01 | Création de l’enregistrementNCT06964685 | Registre d’essai clinique |
| 2026-11-01 | Création de l’enregistrementNCT07422688 | Registre d’essai clinique |
| 2026-11-01 | Création de l’enregistrementNCT07286578 | Registre d’essai clinique |
| 2026-11-01 | Création de l’enregistrementNCT07351643 | Registre d’essai clinique |
| 2026-11-01 | Création de l’enregistrementNCT05410925 | Registre d’essai clinique |
| 2026-11-01 | Début de l’étudeNCT07875088 | Registre d’essai clinique |
| 2026-11-01 | PublicationEffect of hemoperfusion plus hemodialysis on uremic toxins and anemia in patients with maintenance hemodialysis. | Renal failure |
| 2026-11-05 | Dernière mise à jour des donnéesPCI | Biomedical Watch |
| 2026-11-08 | Création de l’enregistrementNCT07684742 | Registre d’essai clinique |
| 2026-11-08 | Création de l’enregistrementNCT07920133 | Registre d’essai clinique |
| 2026-11-09 | Création de l’enregistrementNCT07926022 | Registre d’essai clinique |
| 2026-11-09 | Création de l’enregistrementNCT07762560 | Registre d’essai clinique |
| 2026-11-09 | Création de l’enregistrementNCT06445608 | Registre d’essai clinique |
| 2026-12-01 | Début de l’étudeNCT07920133 | Registre d’essai clinique |
| 2026-12-01 | Fin de l’étude prévue / enregistréeNCT05903950 | Registre d’essai clinique |
| 2026-12-15 | Fin de l’étude prévue / enregistréeNCT04939805 | Registre d’essai clinique |
| 2026-12-31 | Fin de l’étude prévue / enregistréeNCT06154395 | Registre d’essai clinique |
| 2027-01-01 | Début de l’étudeNCT07898709 | Registre d’essai clinique |
| 2027-01-01 | Début de l’étudeNCT07892976 | Registre d’essai clinique |
| 2027-06-01 | Fin de l’étude prévue / enregistréeNCT07926022 | Registre d’essai clinique |
| 2027-06-30 | Fin de l’étude prévue / enregistréeNCT07351643 | Registre d’essai clinique |
| 2027-06-30 | Fin de l’étude prévue / enregistréeNCT07876336 | Registre d’essai clinique |
| 2027-08-01 | Fin de l’étude prévue / enregistréeNCT07898709 | Registre d’essai clinique |
| 2027-08-14 | Fin de l’étude prévue / enregistréeNCT07898696 | Registre d’essai clinique |
| 2027-09-30 | Fin de l’étude prévue / enregistréeNCT07362446 | Registre d’essai clinique |
| 2027-12-31 | Fin de l’étude prévue / enregistréeNCT05410925 | Registre d’essai clinique |
| 2028-03-01 | Fin de l’étude prévue / enregistréeNCT05785897 | Registre d’essai clinique |
| 2028-06-01 | Fin de l’étude prévue / enregistréeNCT06445608 | Registre d’essai clinique |
| 2028-06-01 | Fin de l’étude prévue / enregistréeNCT05701358 | Registre d’essai clinique |
| 2028-08-01 | Fin de l’étude prévue / enregistréeNCT06009874 | Registre d’essai clinique |
| 2028-09-28 | Fin de l’étude prévue / enregistréeNCT07875179 | Registre d’essai clinique |
| 2028-10-30 | Fin de l’étude prévue / enregistréeNCT06964685 | Registre d’essai clinique |
| 2029-10-01 | Fin de l’étude prévue / enregistréeNCT07795398 | Registre d’essai clinique |
| 2029-10-31 | Fin de l’étude prévue / enregistréeNCT07879430 | Registre d’essai clinique |
| 2030-01-01 | Fin de l’étude prévue / enregistréeNCT07286578 | Registre d’essai clinique |
| 2030-11-01 | Fin de l’étude prévue / enregistréeNCT07875088 | Registre d’essai clinique |
| 2031-12-31 | Fin de l’étude prévue / enregistréeNCT02038127 | Registre d’essai clinique |
| 2032-12-31 | Fin de l’étude prévue / enregistréeNCT07920133 | Registre d’essai clinique |
| 2033-01-31 | Fin de l’étude prévue / enregistréeNCT07684742 | Registre d’essai clinique |
| 2035-07-31 | Fin de l’étude prévue / enregistréeNCT07741721 | Registre d’essai clinique |
| 2037-04-01 | Fin de l’étude prévue / enregistréeNCT07762560 | Registre d’essai clinique |
| 2039-09-01 | Fin de l’étude prévue / enregistréeNCT07422688 | Registre d’essai clinique |
| 2044-01-01 | Fin de l’étude prévue / enregistréeNCT07892976 | Registre d’essai clinique |
Début phase actuelle
Non disponible dans les sources synchronisées
Essais cliniques liés
29 essai(s)
Début phase actuelle
Non disponible dans les sources synchronisées
| NCT | Titre | Phase | Statut administratif | Pays | Sponsor |
|---|---|---|---|---|---|
| NCT07926022 | TAVI and PCI in Comparison to SAVR and CABG in Low and Intermediate Risk Patients With Severe Aortic Stenosis | À vérifier | RECRUITING | Egypt | Alexandria University |
| NCT07762560 | DOUBLE-SHOCK — Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock | Non applicable | RECRUITING | Germany | Leipzig Heart Science gGmbH |
| NCT06445608 | PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm | Non applicable | RECRUITING | United States | Kardion Inc |
| NCT07684742 | SAPT-ACS — Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome | Phase 4 | RECRUITING | South Korea | Gyeongsang National University Hospital |
| NCT07920133 | Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD) | Non applicable | NOT_YET_RECRUITING | China | Sir Run Run Shaw Hospital |
| NCT07898696 | Reducing Slow/No-Reflow With Prophylactic High-Dose Intracoronary Adenosine Protocol in ST-Elevation Myocardial Infarction The REFLOW AMI Trial | Non applicable | RECRUITING | Pakistan | Prof Muzaffar Ali Zahidi |
| NCT07898709 | Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI | Phase 2 | NOT_YET_RECRUITING | Egypt | Al-Azhar University |
| NCT06964685 | OASIS-AMICS — Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock | À vérifier | RECRUITING | United States | Abiomed Inc. |
| NCT07422688 | OCTAVE — Optical Coherence Tomography in Acute Vessel Evaluation | Non applicable | ENROLLING_BY_INVITATION | Belgium, Denmark, Estonia, Finland, Italy, Latvia, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom | Aarhus University Hospital Skejby |
| NCT07286578 | A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial) | Non applicable | RECRUITING | United States, Belgium, Spain, United Kingdom | Fundación EPIC |
| NCT07351643 | DAPA-PCAT — CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome | Phase 4 | RECRUITING | China | Shenyang Northern Hospital |
| NCT05410925 | OPTIMA-6 — Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction | Phase 4 | RECRUITING | China | The First Affiliated Hospital with Nanjing Medical University |
| NCT05701358 | COMPLETE-2 — Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease | Non applicable | ACTIVE_NOT_RECRUITING | United States, Australia, Austria, Canada, Denmark, Finland, Germany, Greece, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, Serbia, South Africa, Spain, Sweden, United Kingdom | Population Health Research Institute |
| NCT02915107 | OCT STEMI SOIX — The SORT OUT IX STEMI OCT Trial | Non applicable | COMPLETED | Denmark | Odense University Hospital |
| NCT07892976 | The CORE Platform Trial | Non applicable | NOT_YET_RECRUITING | Belgium, Denmark, Netherlands | Copenhagen Trial Unit, Center for Clinical Intervention Research |
| NCT07741721 | Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2) | Non applicable | RECRUITING | South Korea | Chonnam National University Hospital |
| NCT05903950 | APCIQ-BP — Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure | Non applicable | RECRUITING | Qatar | Weill Cornell Medical College in Qatar |
| NCT06850831 | Early Intracoronary N-Acetylcysteine During Primary PCI in STEMI: A Pilot Randomized Trial of Reperfusion Injury Biomarkers and Functional Recovery | Phase 2 | COMPLETED | Indonesia | dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA |
| NCT07795398 | DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease | Phase 4 | RECRUITING | Denmark | Odense University Hospital |
| NCT07362446 | PROTECT-MI — Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction | Phase 2 | RECRUITING | Australia | Nyrada Pty Ltd |
| NCT04939805 | CRP Apheresis in STEMI | Non applicable | RECRUITING | Austria, Germany | Medical University Innsbruck |
| NCT02038127 | GWPCI — Gangwon PCI Prospective Registry | À vérifier | RECRUITING | South Korea | Yonsei University |
| NCT06154395 | Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction | Non applicable | RECRUITING | China | Harbin Medical University |
| NCT06009874 | Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI | Non applicable | RECRUITING | Egypt | Mohammad Hussien Tantawy Soliman |
| NCT07876336 | Prevalence of CYP2C19 Genetic Polymorphisms Among Egyptian Patients Receiving Clopidogrel Following PCI | À vérifier | ENROLLING_BY_INVITATION | Egypt | October 6 University |
| NCT05785897 | STARS DAPT — STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT | Non applicable | RECRUITING | Switzerland | IGLESIAS Juan Fernando |
| NCT07875088 | RW-DCB — Real-World Outcomes of Drug-Coated Balloon Angioplasty in Coronary Artery Disease | À vérifier | NOT_YET_RECRUITING | Mexico, Spain | Kristian Rivera |
| NCT07875179 | IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI | Phase 4 | NOT_YET_RECRUITING | China | The Affiliated Hospital of Xuzhou Medical University |
| NCT07879430 | ADAPT-DCB — 1-Month Versus 6-Month Dual Antiplatelet Therapy After Successful Drug-Coated Balloon-Only Percutaneous Coronary Intervention | Non applicable | NOT_YET_RECRUITING | Non communiqué | Ulsan University Hospital |
Publications liées
19 publication(s)Publications liées
19 publication(s)| Titre | PMID | DOI | Journal | Date |
|---|---|---|---|---|
| Effect of hemoperfusion plus hemodialysis on uremic toxins and anemia in patients with maintenance hemodialysis. Voir source | 41912453 | 10.1080/0886022X.2026.2642241 | Renal failure | |
| CCL17 combined with CCL19 as a nasal adjuvant enhances the immunogenicity of an anti-caries DNA vaccine in rodents. Voir source | 27546005 | 10.1038/aps.2016.73 | Acta pharmacologica Sinica | |
| Synergy of Coronary Revascularization and Optimal Drug Therapy in Patients With Ischemic Cardiomyopathy and Reduced Left Ventricular Ejection Fraction. Voir source | 41671022 | 10.18087/cardio.2026.1.n3098 | Kardiologiia | |
| Quadratus Lumborum Block During Minimally Invasive Colorectal Surgery: A Tool for Enhanced Recovery. Voir source | 42228437 | 10.1097/DCR.0000000000004308 | Diseases of the colon and rectum | |
| Impact of dual antiplatelet therapy duration after percutaneous coronary intervention on outcomes in acute coronary syndrome patients with and without chronic kidney disease: a nationwide cohort study. Voir source | 42443728 | 10.1080/0886022X.2026.2697379 | Renal failure | |
| "Two for One", Novel Dual Left Anterior Descending Artery (LAD) Variant: Type XIII. Voir source | 34055556 | 10.7759/cureus.14717 | Cureus | |
| Residual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary intervention. Voir source | 25139323 | 10.1016/j.ijcard.2014.08.002 | International journal of cardiology | |
| Preoperative Ultrasound-Guided Stellate Ganglion Block for Prevention of Postoperative Sore Throat After Thoracic Surgery: Study Protocol for a Randomized Controlled Trial. Voir source | 42445935 | 10.2147/JPR.S612817 | Journal of pain research | |
| Head-motion-controlled video goggles: preliminary concept for an interactive laparoscopic image display (i-LID). Voir source | 19670983 | 10.1089/lap.2009.0123 | Journal of laparoendoscopic & advanced surgical techniques. Part A | |
| Comparative effectiveness of percutaneous coronary intervention strategies for coronary small-vessel disease: a network meta-analysis of randomized trials. Voir source | 41631490 | 10.1080/07853890.2026.2623329 | Annals of medicine | |
| Unbiased metabolomics screening for potential biomarkers in patients with In-stent restenosis post percutaneous coronary intervention. Voir source | 41504866 | 10.1080/14017431.2026.2613539 | Scandinavian cardiovascular journal : SCJ | |
| Frailty Status and Outcomes in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a multicentre retrospective cohort study. Voir source | 42411588 | 10.1093/eurjcn/zvag162 | European journal of cardiovascular nursing | |
| Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice. Voir source | 42240074 | 10.1002/ajh.70391 | American journal of hematology | |
| Clinical Impact of Complete Revascularization Before Left Ventricular Assist Device Implantation in Patients With Severe Ischemic Cardiomyopathy. Voir source | 42590810 | 10.1111/aor.70221 | Artificial organs | |
| Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammation. Voir source | 39579287 | 10.1007/s10787-024-01592-y | Inflammopharmacology | |
| Precision Medicine in Transfusion-Dependent and Non-Transfusion-Dependent β-Thalassemia: Toward Personalized Diagnosis and Therapy. Voir source | 42572810 | 10.1080/03630269.2026.2709700 | Hemoglobin | |
| Interventional Diagnostic Procedure: a Practical Guide for the Assessment of Coronary Vascular Function. Voir source | 35377363 | 10.3791/62265 | Journal of visualized experiments : JoVE | |
| 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. Voir source | 27885969 | 10.1186/s13054-016-1208-6 | Critical care (London, England) | |
| Management of multivessel disease in patients with ST-segment elevation myocardial infarction: questioning routine immediate complete revascularization in all patients. Voir source | 42423587 | 10.1097/MCA.0000000000001661 | Coronary artery disease |
Sources officielles
liens de rechercheDernière mise à jour des données : 2026-11-05
Ces sources sont proposées pour vérification. Les informations de la fiche doivent être confirmées dans les registres officiels ou les publications originales.